These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1600412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
    Vogler WR, Somberg LB, Glasser L.
    Exp Hematol; 1987 May; 15(4):360-4. PubMed ID: 3569439
    [Abstract] [Full Text] [Related]

  • 3. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
    Allieri MA, Lopez M, Douáy L, Mary JY, NGuyen L, Gorin NC.
    Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
    [Abstract] [Full Text] [Related]

  • 4. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR, Olson AC, Berdel WE, Okamoto S, Glasser L.
    Prog Clin Biol Res; 1990 Feb; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [Abstract] [Full Text] [Related]

  • 5. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging.
    Moriyama Y, Goto T, Nikkuni K, Aoki A, Furukawa T, Narita M, Koyama S, Kishi K, Takahashi M, Shibata A.
    Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327
    [Abstract] [Full Text] [Related]

  • 6. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
    Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL.
    J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
    [Abstract] [Full Text] [Related]

  • 7. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
    Verdonck LF, Witteveen EO, van Heugten HG, Rozemuller E, Rijksen G.
    Cancer Res; 1990 Jul 01; 50(13):4020-5. PubMed ID: 2354451
    [Abstract] [Full Text] [Related]

  • 8. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V, Kabral A, Bradstock KF.
    Bone Marrow Transplant; 1991 Nov 01; 8(5):351-5. PubMed ID: 1768969
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS, Park HM, Han CH, Park JW, Kim CC, Kim DJ.
    Prog Clin Biol Res; 1992 Nov 01; 377():87-95. PubMed ID: 1438449
    [No Abstract] [Full Text] [Related]

  • 10. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells.
    Dietzfelbinger HF, Lang A, Oberberg D, Rastetter JW, Berdel WE.
    Exp Hematol; 1992 Feb 01; 20(2):178-83. PubMed ID: 1544386
    [Abstract] [Full Text] [Related]

  • 11. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
    Hagenbeek A, Martens AC.
    Leukemia; 1989 Jul 01; 3(7):535-7. PubMed ID: 2659904
    [Abstract] [Full Text] [Related]

  • 12. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep 01; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 13. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
    Yamazaki T, Sieber F.
    Bone Marrow Transplant; 1997 Jan 01; 19(2):113-9. PubMed ID: 9116607
    [Abstract] [Full Text] [Related]

  • 14. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
    Kramer B, Makrynikola V, Bradstock K.
    Prog Clin Biol Res; 1992 Jan 01; 377():41-7. PubMed ID: 1438438
    [No Abstract] [Full Text] [Related]

  • 15. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
    Skala JP, Rogers PC, Chan KW, Rodriguez WC.
    Prog Clin Biol Res; 1992 Jan 01; 377():57-62. PubMed ID: 1332075
    [No Abstract] [Full Text] [Related]

  • 16. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M, Grisanti S, Granzow K, Saladini A, Sala A, Nozza A, Molteni A, Passamonti F, Carlo-Stella C, Santoro A, Siena S.
    Semin Oncol; 1999 Apr 01; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [Abstract] [Full Text] [Related]

  • 17. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview.
    Wötzel M, Brachwitz H, Langen P, Thierbach V.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Apr 01; 117(6):771-6. PubMed ID: 1713880
    [Abstract] [Full Text] [Related]

  • 18. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK, Konings AW.
    Exp Hematol; 1996 Feb 01; 24(2):246-52. PubMed ID: 8641348
    [Abstract] [Full Text] [Related]

  • 19. Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow.
    Vogler WR, Berdel WE.
    J Hematother; 1993 Feb 01; 2(1):93-102. PubMed ID: 7921970
    [Abstract] [Full Text] [Related]

  • 20. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
    Yamazaki T, Sato Y, Sieber F.
    Exp Hematol; 1997 Jul 01; 25(7):629-37. PubMed ID: 9216739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.